| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.082 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |